Kindly MD (NAKA)
NASDAQ:NAKA
Want to see NAKA full AI Analyst Report?
NAKA Stock Chart & Stats
$0.26
--
Market closed
$0.26
--
Day’s Range― - ―
52-Week Range$4.50 - $880.12
Previous CloseN/A
VolumeN/A
Average Volume (3M)30.98M
Market Cap
$86.49M
Enterprise Value$6.19B
Total Cash (Recent Filing)$35.30M
Total Debt (Recent Filing)$209.74M
Price to Earnings (P/E)―
Beta3.99
Next Earnings
Aug 19, 2026EPS Estimate
-0.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-29.55
Shares Outstanding17,402,140
10 Day Avg. Volume32,220,503
30 Day Avg. Volume30,978,537
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.31
Price to Sales (P/S)87.61
P/FCF Ratio-6.72
Enterprise Value/Market Cap71.51
Enterprise Value/Revenue1.58K
Enterprise Value/Gross Profit-419.63
Enterprise Value/Ebitda-22.35
Forecast
1Y Price Target
$27.50Price Target Upside10476.92% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-8
Revenue Forecast (FY)$36.77M
Bulls Say, Bears Say
Bulls Say
Revenue RecoveryA >100% TTM revenue rebound signals meaningful demand recovery and product-market traction. Sustained top-line growth provides the structural basis to absorb fixed costs, achieve scale economies, and justify follow-on investment to drive durable margin improvement if management sustains revenue momentum.
Moderate Leverage And Improved Equity HistoryLeverage at moderate levels gives the company more financing flexibility than highly levered peers. Improvement from prior negative equity indicates balance-sheet repair. A manageable debt load reduces near-term solvency strain and supports structural options for refinancing or capital raises over the medium term.
Governance Steps To Preserve Listing And Leadership ProtectionsThe reverse split and recent board actions are structural moves to maintain Nasdaq listing and institutional access to capital. Coupled with updated indemnification, these governance changes lower delisting risk, stabilize executive recruitment/retention, and preserve avenues for durable capital markets access.
Bears Say
Deeply Negative MarginsSeverely negative gross and net margins indicate the core business does not cover direct costs or operating expenses. This structural profitability gap will erode equity over time, constrain reinvestment, and requires meaningful business-model changes to restore sustainable earnings power.
Persistent And Large Cash BurnConsistently negative operating and free cash flow at material levels signals ongoing funding needs. Persistent cash burn creates structural reliance on external financing, increases dilution or leverage risk, and limits the company's ability to invest in growth without altering cash generation trajectories.
Declining Equity And Negative Returns On CapitalDeclining equity and chronically negative returns show the capital base is not generating value. This undermines long-term financial resilience, raises solvency questions, and makes it harder to attract non-dilutive capital or credit on favorable terms, impeding strategic flexibility.
Kindly MD News
NAKA FAQ
What was Kindly MD’s price range in the past 12 months?
Kindly MD lowest stock price was $4.50 and its highest was $880.12 in the past 12 months.
What is Kindly MD’s market cap?
Kindly MD’s market cap is $86.49M.
When is Kindly MD’s upcoming earnings report date?
Kindly MD’s upcoming earnings report date is Aug 19, 2026 which is in 77 days.
How were Kindly MD’s earnings last quarter?
Kindly MD released its earnings results on May 13, 2026. The company reported -$15.2 earnings per share for the quarter, missing the consensus estimate of -$0.2 by -$15.
Is Kindly MD overvalued?
According to Wall Street analysts Kindly MD’s price is currently Undervalued.
Does Kindly MD pay dividends?
Kindly MD does not currently pay dividends.
What is Kindly MD’s EPS estimate?
Kindly MD’s EPS estimate is -0.61.
How many shares outstanding does Kindly MD have?
Kindly MD has 17,402,140 shares outstanding.
What happened to Kindly MD’s price movement after its last earnings report?
Kindly MD reported an EPS of -$15.2 in its last earnings report, missing expectations of -$0.2. Following the earnings report the stock price went up 8.363%.
Which hedge fund is a major shareholder of Kindly MD?
Currently, no hedge funds are holding shares in NAKA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Kindly MD Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$27.50 (10476.92% Upside)
$27.50 (10476.92% Upside)
Hedge Fund Trend
Increased
By 19.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $992.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 3.2%
Last 30 Days ▼ 3.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.98%
12-Months-Change
Fundamentals
Return on Equity
-84.79%
Trailing 12-Months
Asset Growth
9999.00%
Trailing 12-Months
Company Description
Kindly MD
Nakamoto Inc. develops and invests in a global portfolio of Bitcoin-native companies. It offers commercial and financial infrastructure for the capital markets. The company was formerly known as Kindly MD, Inc. and change its name to Nakamoto Inc. in January 2026. Nakamoto Inc. was incorporated in 2019 and is based in Nashville, Tennessee.
NAKA Stock 12 Month Forecast
Average Price Target
$27.50
▲(10476.92% Upside)
Technical Analysis
EyePoint Pharmaceuticals
―
Inhibrx Biosciences Inc
―
Rapport Therapeutics, Inc.
―
Sila Realty Trust, Inc.
―
Beta Bionics, Inc.
―
Ownership Overview
22.29% Insiders
1.26% Mutual Funds
7.90% Other Institutional Investors
67.30% Public Companies and
Individual Investors